Assignment of Assignor's Interest

Recorded: 2022-02-15 Pages: 4

Assignor

NEWGEN THERAPEUTICS, INC.

Executed: 2021-05-19

Assignee

RAKOVINA THERAPEUTICS INC.

2201-8 SMITHE MEWS, VANCOUVER, BRITISH COLUMBIA, V6B 0A5, CANADA

Covered Property (1)

Tricyclic Inhibitors of Poly(Adp-Ribose)Polymerase

Application: 17/671,436 →

Publication: US 2023/0027257

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.